PARP Inhibitors in Ovarian Cancer: Experts Discuss Patient Cases and the Current Paradigm

Listen to Nicoletta Colombo, MD; Philipp Harter, MD, PhD; and Alexandra Leary, MD, PhD, discuss patient cases from a live CCO webinar on the current paradigm and long-term benefits of PARPi therapy in the treatment of ovarian cancer.